2-Year Clinical and Angiographic Outcomes From a Randomized Trial of Polymer-Free Dual Drug-Eluting Stents Versus Polymer-Based Cypher and Endeavor, Drug-Eluting Stents
- 8 June 2010
- journal article
- research article
- Published by Elsevier BV in Journal of the American College of Cardiology
- Vol. 55 (23), 2536-2543
- https://doi.org/10.1016/j.jacc.2010.03.020
Abstract
No abstract availableKeywords
Funding Information
- European Society of Cardiology
- Bavarian Research Foundation (BFS-ISAR Aktenzeichen AZ: 504/02, BFS-DES Aktenzeichen AZ: 668/05)
This publication has 19 references indexed in Scilit:
- Randomized, non-inferiority trial of three limus agent-eluting stents with different polymer coatings: the Intracoronary Stenting and Angiographic Results: Test Efficacy of 3 Limus-Eluting Stents (ISAR-TEST-4) TrialEuropean Heart Journal, 2009
- Two-Year Clinical, Angiographic, and Intravascular Ultrasound Follow-Up of the XIENCE V Everolimus-Eluting Stent in the Treatment of Patients With De Novo Native Coronary Artery LesionsCirculation: Cardiovascular Interventions, 2009
- Finn AV, Nakazawa G, Kolodgie FD, Virmani R. Temporal Course of Neointimal Formation After Drug-Eluting Stent Placement: Is Our Understanding of Restenosis Changing? J Am Coll Cardiol Intv 2009;2:300–2JACC: Cardiovascular Interventions, 2009
- Temporal Course of Neointimal Formation After Drug-Eluting Stent Placement: Is Our Understanding of Restenosis Changing?JACC: Cardiovascular Interventions, 2009
- Durability of Antirestenotic Efficacy in Drug-Eluting Stents With and Without Permanent PolymerКАРДИОЛОГИЯ УЗБЕКИСТАНА, 2009
- The pre-clinical assessment of rapamycin-eluting, durable polymer-free stent coating conceptsBiomaterials, 2009
- A polymer-free dual drug-eluting stent in patients with coronary artery disease: a randomized trial vs. polymer-based drug-eluting stentsEuropean Heart Journal, 2008
- The Significance of Preclinical Evaluation of Sirolimus-, Paclitaxel-, and Zotarolimus-Eluting StentsThe American Journal of Cardiology, 2007
- Overview of Pharmacology and Clinical Trials Program with the Zotarolimus‐Eluting Endeavor StentJournal of Interventional Cardiology, 2006
- Impact of Routine Angiographic Follow-Up on the Clinical Benefits of Paclitaxel-Eluting Stents: Results From the TAXUS-IV TrialJournal of the American College of Cardiology, 2006